OP0225 Evaluation of response to adjuvanted recombinant zoster vaccination in patients with rheumatoid arthritis receiving upadacitinib: Results from a randomized trial sub-study
Recommended Citation
Winthrop K, Klaff J, Liu Y, et al. OP0225 Evaluation of response to adjuvanted recombinant zoster vaccination in patients with rheumatoid arthritis receiving upadacitinib: Results from a randomized trial sub-study. Annals of the Rheumatic Diseases. 2023;82(Suppl 1):148-148. doi:10.1136/annrheumdis-2023-eular.2386
Document Type
Abstract